SUCCIPRO

We are a spin-off company from Pere Virgili Health Research institute (IISPV) and Rovira Virgili University. We are expert in succinate and are developing first-in-class molecules able to modulate succinate, a metabolite with pro-inflammatory properties that is increased in many metabolic and inflammatory disorders. The company has a diversified pipeline of candidates at an early preclinical phase and is working with several clinical indicacions, which include Type 2 Diabetes, obesity, Inflammatory bowel Disease and Non-Alcoholic Steatohepatitis